RhumbLine Advisers’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Buy |
75,950
+75,159
| +9,502% | +$301K | ﹤0.01% | 2981 |
|
|
2025
Q1 | $2.52K | Hold |
791
| – | – | ﹤0.01% | 3966 |
|
|
2024
Q4 | $4.23K | Hold |
791
| – | – | ﹤0.01% | 3975 |
|
|
2024
Q3 | $4.18K | Hold |
791
| – | – | ﹤0.01% | 4003 |
|
|
2024
Q2 | $1.44K | Hold |
791
| – | – | ﹤0.01% | 4211 |
|
|
2024
Q1 | $1.41K | Hold |
791
| – | – | ﹤0.01% | 4117 |
|
|
2023
Q4 | $1.39K | Hold |
791
| – | – | ﹤0.01% | 4126 |
|
|
2023
Q3 | $1.15K | Hold |
791
| – | – | ﹤0.01% | 4169 |
|
|
2023
Q2 | $1.81K | Buy |
+791
| New | +$1.81K | ﹤0.01% | 4229 |
|
|
2019
Q2 | – | Sell |
-17,853
| Closed | -$72K | – | 2976 |
|
|
2019
Q1 | $72K | Sell |
17,853
-350
| -2% | -$1.41K | ﹤0.01% | 2896 |
|
|
2018
Q4 | $67K | Buy |
18,203
+5,570
| +44% | +$20.5K | ﹤0.01% | 2920 |
|
|
2018
Q3 | $108K | Sell |
12,633
-800
| -6% | -$6.84K | ﹤0.01% | 2854 |
|
|
2018
Q2 | $147K | Buy |
+13,433
| New | +$147K | ﹤0.01% | 2809 |
|